Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Rating) CEO John E. Kao sold 39,101 shares of the firm’s stock in a transaction that occurred on Tuesday, March 14th. The shares were sold at an average price of $6.33, for a total value of $247,509.33. Following the completion of the sale, the chief executive officer now directly owns 2,381,279 shares in the company, valued at approximately $15,073,496.07. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Alignment Healthcare Trading Down 1.2 %
Shares of ALHC opened at $6.01 on Friday. The stock has a fifty day moving average price of $10.26 and a two-hundred day moving average price of $11.81. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.37 and a current ratio of 2.37. Alignment Healthcare, Inc. has a 52-week low of $5.76 and a 52-week high of $19.17. The company has a market cap of $1.13 billion, a price-to-earnings ratio of -7.33 and a beta of 1.86.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on ALHC shares. Piper Sandler decreased their price objective on Alignment Healthcare from $19.00 to $12.00 and set an “overweight” rating on the stock in a report on Friday, March 3rd. Raymond James lowered Alignment Healthcare from an “outperform” rating to a “market perform” rating in a report on Monday, November 21st. The Goldman Sachs Group decreased their price objective on Alignment Healthcare from $21.00 to $14.00 and set a “buy” rating on the stock in a report on Friday, March 3rd. TD Cowen decreased their price objective on Alignment Healthcare from $17.00 to $10.00 and set an “outperform” rating on the stock in a report on Thursday, March 2nd. Finally, JPMorgan Chase & Co. lowered Alignment Healthcare from an “overweight” rating to a “neutral” rating and decreased their price objective for the stock from $22.00 to $12.00 in a report on Thursday, February 23rd. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, Alignment Healthcare currently has an average rating of “Moderate Buy” and an average target price of $15.64.
Hedge Funds Weigh In On Alignment Healthcare
Alignment Healthcare Company Profile
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, Nevada, and Arizona.
- Get a free copy of the StockNews.com research report on Alignment Healthcare (ALHC)
- Don’t Miss Out: $2 Trillion Could be Headed to the Banking Sector
- A Weakening Economy Suggests Caution Before Buying Five Below
- Williams-Sonoma: Time To Buy At Rock-Bottom Prices
- Why DraftKings Could Keep Outperforming in 2023
- Charles Schwab And The Safest 30% You Can Make This Year
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.